Specimen Validity Testing Market – Global Forecast to 2023

DUBLIN, May 29, 2018 /PRNewswire/ —

The “Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.

The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%.

The growth of the specimen validity testing market is primarily driven by the growth in drug screening market and increase in workplace drug testing.

The report segments the global specimen validity testing market by product and service, type, end user, and region.

The specimen validity testing market is broadly segmented into products and services. The services segment is expected to register the highest growth rate during the forecast period. The high growth in this segment is attributed to the implementation of workplace drug testing in several countries, increase in the number of drug screening tests, and growing number of drug screening laboratories across the globe.

Based on product, the specimen validity testing market is categorized into reagents, calibrators, & controls; assay kits; and disposables. In 2018, the reagents, calibrators, and controls segment is expected to account for the largest share of the market, owing to the repeated purchase of these products.

The global specimen validity testing market by type is segmented into laboratory testing and rapid/POC testing. In 2018, the laboratory testing segment is expected to account for the largest share of the market. However, the rapid/POC testing segment is expected to register the highest growth during the forecast period. The high growth of the rapid/POC testing segment can be attributed benefits such as instant results, ability to detect multiple drugs at once, and the recurrent & repetitive usage of rapid/POC drug testing products.

Based on end user, the specimen validity testing market is segmented into workplaces, drug screening laboratories, criminal justice and law enforcement agencies, pain management centers, drug rehabilitation centers, and other end users. In 2018, the workplaces segment is expected to account for the largest share of the market. The growth in this segment can be attributed to the increasing incidence of substance abuse in the workplace and the growing number of organizations that have made regular drug screening mandatory.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Specimen Validity Testing Market Overview
4.2 Specimen Validity Testing Market, By Type (2018 vs 2023)
4.3 Specimen Validity Testing Products Market, By Type (2018 vs 2023)
4.4 Geographic Analysis: European Specimen Validity Testing Market, By End User and Region (2018)
4.5 Geographic Snapshot: Specimen Validity Testing Market (2018-2023)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growth in the Drug Screening Market
5.2.1.2 Increase in Workplace Drug Testing
5.2.2 Restraints
5.2.2.1 Emergence of Alternative Drug Screening Tests
5.2.3 Market Opportunities
5.2.3.1 Rapid/Point-Of-Care Specimen Validity Testing
5.2.4 Market Trends
5.2.4.1 Market Consolidation
5.2.4.2 Regulatory Approvals for Rapid Testing Products

6 Specimen Validity Testing Market, By Product & Service
6.1 Introduction
6.2 Products
6.2.1 Reagents, Calibrators, and Controls
6.2.2 Assay Kits
6.2.3 Disposables
6.3 Services

7 Specimen Validity Testing Market, By Type
7.1 Introduction
7.2 Laboratory Testing
7.3 Rapid/PoC Testing

8 Specimen Validity Testing Market, By End User
8.1 Introduction
8.2 Workplaces
8.3 Drug Screening Laboratories
8.4 Criminal Justice and Law Enforcement Agencies
8.5 Pain Management Centers
8.6 Drug Rehabilitation Centers
8.7 Other End Users

9 Specimen Validity Testing Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Rest of Europe (RoE)
9.4 Asia Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape
10.1 Introduction
10.2 Market Ranking Analysis, By Key Player
10.3 Competitive Scenario
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.3.3 Partnership, Agreements, and Collaboration
10.3.4 Expansions

11 Company Profiles
11.1 Alere (Subsidiary of Abbott Laboratories)
11.2 Thermo Fisher Scientific
11.3 LabCorp
11.4 Quest Diagnostics
11.5 American Bio Medica Corporation (ABMC)
11.6 Sciteck
11.7 Premier Biotech
11.8 Alfa Scientific Designs
11.9 ACM Global Laboratories
11.10 Express Diagnostic International
11.11 Clinical Reference Laboratory

For more information about this report visit https://www.researchandmarkets.com/research/pm6bl4/specimen_validity?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/specimen-validity-testing-market—global-forecast-to-2023-300655731.html

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com